Sign inJoin waitlistJoin the waitlist

Christopher Anker

Program Co-Leader, Cancer Host and Environment, UVM Cancer Center · Robert Larner College of Medicine

Credentials: · · · ·

History

Cancer Host and Environment · Robert Larner College of Medicine
Present
Robert Larner College of Medicine
Present

Radiation Oncology
University of Utah School of Medicine
2009–2014
Internal Medicine
SUNY Upstate Medical University
2006–2009
State University of New York
2005–2006
SUNY Upstate Medical University Coll of Med
2001–2005
Cornell University (Non Med) - Chemical Engineering

Research

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical…
JAMA Oncology · 2017 · 190 citations
Melanoma, version 2.2013: featured updates to the NCCN guidelines
Journal of the National Comprehensive Cancer Network · 2013 · 123 citations
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)
Review · International journal of radiation oncology · 2016 · First of 6 authors · Corresponding · 117 citations

Navesh Sharma
16 papers · 2 as a resident
Percy Lee
16 papers
Timothy Kennedy
16 papers
Chris Hallemeier
15 papers
Leila Tchelebi
15 papers
SR
Suzanne Russo
15 papers
William Small
15 papers
DS
Dennis Shrieve
14 papers
Salma Jabbour
14 papers
Krishan Jethwa
13 papers
Dmitriy Akselrod
10 papers
Gerard Abood
10 papers

Clinical trials

Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma
Principal investigator · Enrolling by invitation · Phase 2
University of Vermont Medical Center
2026–2040
Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma
Principal investigator · Terminated · Phase 2
University of Utah
2009–2012
Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial
Site PI · Recruiting · Phase 2
University of Vermont Medical Center
2025–2030
MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
Site PI · Recruiting · Phase 2
University of Vermont Medical Center
2025–2031